After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Fate Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Fate Therapeutics Inc is $159.45M. A total of 0.55 million shares were traded on the day, compared to an average of 3.21M shares.
In the most recent transaction, Bressi Jerome Charles sold 5,980 shares of FATE for 1.55 per share on Jan 10 ’25. After the transaction, the insider now owns 270,203 company shares. In a previous transaction on Jan 10 ’25, TAHL CINDY sold 5,654 shares at 1.55 per share. FATE shares that the insider owns now total 336,707.
Among the insiders who sold shares, Valamehr Bahram disposed of 8,705 shares on Jan 10 ’25 at a per-share price of $1.54. This resulted in the President and CEO holding 349,364 shares of FATE after the transaction. In another insider transaction, Valamehr Bahram bought 8,705 shares at $1.54 per share on Jan 10 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, FATE has a high of $8.83 and a low of $1.04.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. FATE’s latest balance sheet shows that the firm has $615.91M in Cash & Short Term Investments as of fiscal 2021. There were $114.82M in debt and $81.28M in liabilities at the time. Its Book Value Per Share was $3.18, while its Total Shareholder’s Equity was $678.84M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FATE is Buy with a score of 3.67.
